Phase I study of lapatinib and pemetrexed in the second-line treatment of advanced or metastatic non-small-cell lung cancer with assessment of circulating cell free thymidylate synthase RNA as a potential biomarker - Ramlau, Rodryg; Thomas, Michael (Clinical lung cancer, 2015)
Gesehen am 04.01.2017